Results

1–10 of 13 results for retinopathy of prematurity (ROP)

The incidence and timing of treatment-requiring retinopathy of prematurity (ROP) in nanopremature and micropremature infants in the United States
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2023
National vs International Outcomes and Practice Patterns of Intravitreal Anti-VEGF Injections for Retinopathy of Prematurity
Nimesh A. Patel, MD
Annual Meeting Talks
2022
Improved Survival of Micro-Premature Infants: Influence on Retinopathy of Prematurity Development, Presentation and Treatment
Parampal S. Grewal, MD, FRCSC, ABO
On Demand Cases, Courses, and Papers
2021
Computerized Analysis of Retinal Vascular Growth Following Intravitreal Bevacizumab Monotherapy in Retinopathy of Prematurity Until Three Years of Age
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
2021
Laser Photocoagulation for Type 2 Retinopathy of Prematurity (ROP) or Less: When and Why?
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2020
Retinopathy of Prematurity S/P Laser Complications
Giselle DeOliveira
Retina Image Bank: Images of the Week
2020
Economic Impact of the Use of Anti-VEGF Monotherapy or in Combination With Panretinal Photocoagulation in the Treatment of Retinopathy of Prematurity
Swati Agarwal-Sinha, MD, FASRS
Updates from the Field
2019
HIPPA and Malpractice Pitfalls in Providing Care to Infants at Risk for Retinopathy of Prematurity (ROP) For Physicians Employing Digital Imaging Technologies
Antonio Capone, MD
Annual Meeting Talks
2016
Intravitreal Injection of Bevacizumab or Laser for Management of Retinopathy of Prematurity
Varun Chaudhary, MD
On Demand Cases, Courses, and Papers
2017
Plus Disease
Anna L. Ells, MD, FRCS(C)
Updates from the Field
2017